Sarepta Therapeutics Inc.

62.33
0.42 (0.68%)
At close: Apr 02, 2025, 3:59 PM
57.50
-7.75%
After-hours: Apr 02, 2025, 05:31 PM EDT

Sarepta Therapeutics Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98 FY97 FY96 FY95
Revenue 1.9B 1.24B 933.01M 701.89M 540.1M 380.83M 301.03M 154.58M 5.42M 1.25M 9.76M 14.22M 37.33M 46.99M 29.42M 17.59M 21.26M 10.99M 115.29K 4.78M 430.46K 969.87K 836.78K 706.1K 1.3M 100K 200K 100K 100K 100K
Cost of Revenue 319.1M 150.34M 139.99M 97.05M 63.38M 56.59M 34.19M 7.35M 130K 146.19M 94.1M 90.28M 51.93M 35.93M 27.46M n/a n/a n/a n/a n/a n/a n/a n/a n/a -416.5K n/a -200K -500K -500K n/a
Gross Profit 1.58B 1.09B 793.02M 604.84M 476.72M 324.25M 266.84M 147.23M 5.29M -144.94M -84.35M -76.06M -14.6M 11.06M 1.96M 17.59M 21.26M 10.99M 115.29K 4.78M 430.46K 969.87K 836.78K 706.1K 1.71M 100K 400K 600K 600K 100K
Operating Income 218.08M -267.82M -536.2M -449.71M -564.16M -522.32M -343.63M -171.64M -266.73M -220.18M -133.79M -90.28M -29.7M -35.93M -20.93M -15.51M -27.46M -33.11M -32.98M -17.52M -25.04M -18.87M -25.34M -15.4M -10.24M -8.3M -7.7M -3.9M -2.2M -2.6M
Interest Income 71.77M 85.97M 16.49M 354K 2.97M 7.24M 6.81M 1.81M 507K n/a n/a n/a n/a 677K n/a n/a n/a n/a 1.91M 840.5K n/a 491.1K n/a n/a 1M n/a n/a n/a n/a n/a
Pretax Income 260.77M -520.1M -689.96M -418.95M -553.07M -713.88M -362.61M -48.63M -267.26M -220.03M -135.79M -111.98M -121.29M -2.32M -23.95M -24.7M -23.95M -28.15M -31.07M -16.68M -24.78M -14.62M -29.36M -8.28M -9.24M -8.4M -26.7M -3.5M -2M -2.6M
Net Income 235.24M -535.98M -703.49M -418.78M -554.13M -715.08M -361.92M -50.69M -267.26M -220.03M -135.79M -111.98M -121.29M -2.32M -32.18M -25.16M -23.95M -27.17M -31.07M -16.68M -24.78M -14.62M -29.36M -26.93M -9.24M -8.3M -26.7M -3.6M -2.1M -2.6M
Selling & General & Admin 557.87M 481.87M 451.42M 282.66M 317.88M 284.81M 207.76M 122.68M 83.75M 75.04M 49.31M 31.59M 14.63M 16.05M 14.38M 8.7M 9.8M 9.33M 7.75M 5.18M 4.74M 4.56M 3.76M 3.36M 2.27M 1.7M 1.6M 1.3M 600K 600K
Research & Development 804.52M 877.39M 877.09M 771.18M 722.34M 560.91M 401.84M 166.71M 188.27M 146.39M 94.23M 72.91M 52.4M 66.86M 35.97M 24.4M 29M 34.76M 25.35M 17.12M 20.74M 15.28M 22.41M 12.75M 9.27M 6.7M 6.3M 2.7M 1.7M 2.1M
Other Expenses 2.4M 1.56M 714K 706K 662K 849K -656K 1.98M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 416.5K n/a 200K 500K 500K n/a
Operating Expenses 1.36B 1.36B 1.33B 1.05B 1.04B 846.57M 610.47M 290.44M 272.02M 221.44M 143.55M 104.5M 67.03M 82.92M 50.35M 33.09M 38.8M 44.09M 33.1M 22.3M 25.47M 19.84M 26.18M 16.11M 11.96M 8.4M 8.1M 4.5M 2.8M 2.7M
Interest Expense 18.39M 22.01M 53.25M 63.52M 59.95M 30.67M 33.71M 5.78M 1.89M n/a n/a 326K n/a 90K 344K 454K 344K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a 28.6M 14.6M 7.7M n/a n/a -2.22M 2.83M 2.55M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 1.68B 1.51B 1.47B 1.15B 1.1B 903.16M 644.66M 297.8M 272.15M 221.44M 143.55M 104.5M 67.03M 82.92M 50.35M 33.09M 38.8M 44.09M 33.1M 22.3M 25.47M 19.84M 26.18M 16.11M 11.54M 8.4M 7.9M 4M 2.3M 2.7M
Income Tax 25.54M 15.88M 13.53M -168K 1.06M 1.2M -692K 2.06M -7.62M -5.25M -1.69M 20.42M 91.58M -34.91M 11.24M 9.65M 6.41M -5.94M n/a n/a n/a -4.26M 4.02M 11.52M n/a n/a 19M -300K -100K n/a
Shares Outstanding (Basic) 95.08M 92.4M 87.56M 81.26M 77.96M 73.61M 66.25M 58.82M 48.68M 42.29M 40.03M 33.83M 23.6M 21.6M 18.54M 15.52M 11.58M 8.99M 8.78M 7.44M 6M 4.97M 4.28M 3.73M 3.12M 2.24M 1.97M 1.68M 1.4M 1.2M
Shares Outstanding (Diluted) 107.88M 92.4M 87.56M 81.26M 77.96M 73.61M 66.25M 58.82M 48.7M 42.29M 40.03M 33.85M 23.6M 21.6M 18.54M 15.52M 11.58M 8.99M 8.78M 7.44M 6M 4.97M 4.28M 3.73M 3.12M 2.24M 1.97M 1.68M 1.4M 1.2M
EPS (Basic) 2.47 -5.8 -8.03 -5.15 -7.11 -9.71 -5.46 -0.86 -5.49 -5.2 -3.39 -3.31 -5.14 -0.11 -1.74 -1.62 -2.07 -3.02 -3.54 -2.24 -4.13 -2.94 -6.86 -7.21 -2.96 -3.71 -13.57 -2.14 -1.5 -2.17
EPS (Diluted) 2.18 -5.8 -8.03 -5.15 -7.11 -9.71 -5.46 -0.86 -5.49 -5.2 -3.39 -3.31 -5.14 -0.11 -1.74 -1.62 -2.07 -3.02 -3.54 -2.24 -4.13 -2.94 -6.86 -7.21 -2.96 -3.71 -13.57 -2.14 -1.5 -2.17
EBITDA 316.89M -439.2M -582.12M -306.08M -453.38M -652.66M -316.66M -34.75M -261.12M -214.78M -129.97M -88.42M -27.59M -34.63M -19.47M -14.13M -22.48M -25.15M -28.98M -14.68M -22.89M -17.39M -24.01M -14.85M -9.82M -8M -7.6M -3.4M -1.7M -2.1M
EBIT 279.17M -498.09M -636.72M -355.42M -493.12M -683.21M -328.9M -42.83M -266.73M -218.66M -133.79M -90.28M -29.7M -35.93M -20.93M -15.51M -17.54M -33.11M -32.98M -17.52M -25.04M -18.87M -25.34M -15.4M -10.24M -8.3M -7.8M -3.9M -2.2M n/a
Depreciation & Amortization 37.72M 58.89M 54.6M 49.34M 39.74M 30.55M 12.24M 8.09M 5.61M 5.25M 3.69M 1.28M 1.52M 1.3M 1.46M 1.38M 1.47M 2.01M 2.09M 2M 1.89M 1.48M 1.33M 556.47K 416.5K 300K 200K 500K 500K 500K